Fotios Plakogiannis
Founder at Transdermal Research Pharm Laboratories LLC
Fotios Plakogiannis active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Transdermal Research Pharm Laboratories LLC | Founder | 2012-12-31 | - |
| President | 2012-12-31 | - | |
ChemioCare, Inc.
 ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | Director/Board Member | - | - |
Starton Therapeutics, Inc.
 Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Director/Board Member | - | - |
Career history of Fotios Plakogiannis
Former positions of Fotios Plakogiannis
| Companies | Position | Start | End |
|---|---|---|---|
| AEQUUS PHARMACEUTICALS INC. | Director/Board Member | 2014-01-02 | 2018-07-09 |
| Chairman | 2013-02-24 | 2014-12-09 | |
| Founder | 2013-01-02 | 2018-07-09 | |
| Long Island University | Corporate Officer/Principal | 1966-12-31 | 2010-12-31 |
| Arnold & Marie Schwartz College of Pharmacy & Health Science | Corporate Officer/Principal | - | - |
Training of Fotios Plakogiannis
| University of Southern California | Doctorate Degree |
| The Ohio State University | Graduate Degree |
Statistics
International
| United States | 8 |
| Canada | 2 |
Operational
| Director/Board Member | 4 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| AEQUUS PHARMACEUTICALS INC. | Health Technology |
| Private companies | 3 |
|---|---|
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | Health Technology |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Health Technology |
| Transdermal Research Pharm Laboratories LLC |
- Stock Market
- Insiders
- Fotios Plakogiannis
- Experience
